6113:TSEAMADA Co., Ltd. Analysis
Data as of 2026-03-11 - not real-time
HK$1.61
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
BitStrat Holdings is trading at HK$1.61, well below its 20‑day SMA of 1.74 and far beneath the 200‑day SMA of 3.91, underscoring a pronounced bearish bias. The RSI sits at 22, indicating the stock is oversold and could be vulnerable to a short‑term bounce. MACD lines are virtually flat with a bullish signal, and volume is trending upward, which may provide modest support for a rebound. However, the 30‑day volatility of 38.5% and a historic max drawdown of nearly 79% highlight substantial price instability. The beta of 0.04 suggests near‑market‑neutral price movements, but the low beta does not offset the extreme volatility observed. Moreover, the company’s PE of 32.2 far exceeds the industry average of 18.2, and the DCF‑derived fair value of $0.39 is less than a quarter of the current price.
Fundamentally, revenue is contracting (-2.7%) and the firm carries a high debt‑to‑equity ratio of 81%, while generating no dividend. Cash flow remains positive but modest relative to debt, raising concerns about financial resilience. Given the overvalued price, weak growth prospects, and lack of dividend income, the stock leans toward a value‑oriented assessment rather than a growth play. The combination of high valuation multiples, elevated volatility, and significant historical drawdowns suggests a cautious stance. Consequently, the recommendation is to hold in the very short term, but to consider selling for medium and long horizons. Investors should monitor any shifts in regulatory environment or revenue trends before altering exposure.
Fundamentally, revenue is contracting (-2.7%) and the firm carries a high debt‑to‑equity ratio of 81%, while generating no dividend. Cash flow remains positive but modest relative to debt, raising concerns about financial resilience. Given the overvalued price, weak growth prospects, and lack of dividend income, the stock leans toward a value‑oriented assessment rather than a growth play. The combination of high valuation multiples, elevated volatility, and significant historical drawdowns suggests a cautious stance. Consequently, the recommendation is to hold in the very short term, but to consider selling for medium and long horizons. Investors should monitor any shifts in regulatory environment or revenue trends before altering exposure.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Oversold RSI suggests potential short‑term bounce
- Price trading below major moving averages signals bearish bias
- Increasing volume could support a rebound
Medium Term
1–3 yearsCautious
Model confidence: 7/10
Key Factors
- Price significantly above DCF fair value indicates overvaluation
- Persistent bearish trend and weak revenue growth
- High volatility and large historical drawdown
Long Term
> 3 yearsCautious
Model confidence: 8/10
Key Factors
- Lack of dividend and high valuation multiples
- Sector competitive pressure and regulatory exposure
- Continued cash‑flow constraints relative to debt
Key Metrics & Analysis
Financial Health
Revenue Growth-2.70%
Profit Margin11.92%
P/E Ratio32.2
ROE23.36%
ROA10.60%
Debt/Equity80.99
P/B Ratio6.9
Op. Cash FlowHK$12.7M
Free Cash FlowHK$10.6M
Industry P/E18.2
Technical Analysis
TrendBearish
RSI22.3
SupportHK$1.50
ResistanceHK$1.77
MA 20HK$1.74
MA 50HK$1.89
MA 200HK$3.91
MACDBullish
VolumeIncreasing
Fear & Greed Index77.32
Valuation
Fair ValueHK$0.39
GradeOvervalued
TypeValue
Risk Assessment
Beta0.04
Volatility38.52%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.